The West London Renal and Transplant Centre, Imperial College, London, UK.
Clin Transplant. 2011 May-Jun;25(3):E312-9. doi: 10.1111/j.1399-0012.2011.01418.x. Epub 2011 Mar 1.
Development of live donor kidney transplantation (LDKT) programs has intensified debate regarding acceptability of certain donor categories and potential commercialization. Concerning these issues, we surveyed the views of medical and nursing staff caring for patients with renal failure and renal transplant recipients and donors. Participants were recruited from a tertiary transplant unit and invited to complete an anonymous questionnaire. Four hundred and sixty-four participants completed the questionnaire (42% response). One hundred and sixty-eight (36.2%) were health care professionals and 296 (63.8%) patients; 85.6% of participants were willing to donate to their children, 80.2% to siblings, 80.8% to parents, 72% to a non-blood-related relative or friend, and 15.3% to a stranger. If participants had hypothetical renal failure, they were prepared to accept a kidney from a parent (79.5%), sibling (78.7%), child (56.3%), a non-blood-related relative or friend (79.3%), or stranger (54.1%). Regarding commercialization, responders' attitudes were that the donor should not accept financial reward (29.1%), be compensated for expenses only (60.6%), or should receive a direct financial reward (10.1%). For non-directed donation, 23.5%, 55.6%, and 20.7% were not in support of reward, compensation only, and financial reward, respectively. While live kidney donation was accepted by the majority of individuals surveyed, only the minority approved of commercialization.
活体供肾移植（LDKT）项目的发展加剧了人们对某些供体类别和潜在商业化的可接受性的争论。针对这些问题，我们调查了照顾肾衰竭患者和肾移植受者和供者的医护人员的意见。参与者从一家三级移植单位招募，并被邀请完成一份匿名问卷。共有 464 名参与者完成了问卷（占 42%的回复率）。其中 168 人（36.2%）是医疗保健专业人员，296 人（63.8%）是患者；85.6%的参与者愿意将肾脏捐给自己的孩子，80.2%捐给兄弟姐妹，80.8%捐给父母，72%捐给非血缘亲属或朋友，15.3%捐给陌生人。如果参与者有假设的肾衰竭，他们准备接受来自父母（79.5%）、兄弟姐妹（78.7%）、孩子（56.3%）、非血缘亲属或朋友（79.3%）或陌生人（54.1%）的肾脏。关于商业化，回答者的态度是，供体不应该接受经济奖励（29.1%），只应该补偿费用（60.6%），或者应该获得直接的经济奖励（10.1%）。对于非定向捐赠，分别有 23.5%、55.6%和 20.7%的人不支持奖励、仅补偿和经济奖励。虽然大多数接受调查的人都接受活体肾脏捐赠，但只有少数人赞成商业化。
